Ingalls & Snyder LLC Increases Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Ingalls & Snyder LLC grew its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 13.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 338,779 shares of the pharmacy operator’s stock after acquiring an additional 40,570 shares during the quarter. Ingalls & Snyder LLC’s holdings in Walgreens Boots Alliance were worth $3,161,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in WBA. First Financial Corp IN boosted its position in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 885 shares during the period. Golden State Wealth Management LLC acquired a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth $26,000. TD Private Client Wealth LLC raised its position in shares of Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 3,208 shares during the period. Sentry Investment Management LLC acquired a new stake in shares of Walgreens Boots Alliance during the third quarter worth $30,000. Finally, Eastern Bank acquired a new position in Walgreens Boots Alliance during the third quarter valued at $33,000. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Stock Performance

Walgreens Boots Alliance stock opened at $9.47 on Thursday. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $22.55. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The stock has a 50-day simple moving average of $10.25 and a 200 day simple moving average of $9.77.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. The company had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business’s revenue was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.66 earnings per share. As a group, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have commented on the company. Truist Financial lowered their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Bank of America increased their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Royal Bank of Canada increased their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 15th. UBS Group increased their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Finally, Barclays raised their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 16th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Walgreens Boots Alliance has an average rating of “Hold” and a consensus target price of $13.19.

Check Out Our Latest Research Report on Walgreens Boots Alliance

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Articles

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.